Search
Matt Callahan says Mr Ippolito has enviable track record.

Botanix lines up exec chair appointment

Botanix Pharmaceuticals has appointed Vince Ippolito as its president in the US, and subject to shareholder approval, he will also assume the role of executive chairman for the company.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Share Price

Closing price for the last 90 trading days
Powered by Morningstar ®

Top 10 Shareholders

Substantial shareholders as published in the annual report.
Powered by Morningstar ®

Total Shareholder Return as at 28/02/20

1 year TSR5 year TSR
77thResApp Health86%93%
379thMustera Property Group-6%6%
487thProteomics International Laboratories-20%
550thBotanix Pharmaceuticals-32%27%
701stDXN-53%
671 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

21/02/20
$0 Other
11/12/19
$27k Other
18/07/19
$0 Issued
Total value as at the date of the transaction
Powered by Morningstar ®

Revenue

93rd↑Botanix Pharmaceuticals$4.7m
101st↓Mustera Property Group$3.1m
104th↑ResApp Health$2.7m
106th↑Proteomics International Laboratories$2.7m
108th-DXN$2.6m
198 listed industrial companies ranked by revenue.
Powered by Morningstar ®